Celgene to buy BeiGene stake, to develop tumor cancer treatment

(Reuters) - Biopharmaceutical company Celgene Corp will buy a stake in BeiGene Ltd and help develop and commercialize BeiGene's investigational treatment for tumor cancers, the companies said on Wednesday.

Celgene will acquire 32.7 million, or 5.9 percent of BeiGene's ordinary shares, at $4.58 each, or $59.55 per BeiGene's American Depositary Shares (ADS), they said in a statement.

BeiGene will receive $263 million in upfront license fees and $150 million equity investment. The company will also be eligible to receive up to $980 million in development, regulatory and sales milestone payments.

BeiGene will acquire Celgene's operations in China and will also license and assume commercial responsibility for Celgene's approved therapies in China.

BeiGene's advanced clinical-stage investigational tumor cancer treatment, BGB-A317, is a type of antibody that belongs to a class of immuno-oncology agents known as immune checkpoint inhibitors.

The treatment has been tested in over 500 patients, with initial clinical data suggesting that it is well tolerated and exhibits anti-tumor activity across a range of solid tumor types, the companies said.

BeiGene will retain exclusive global rights for the development and commercialization of BGB-A317 for malignancies related to blood-forming tissues and for solid tumors in Asia, excluding Japan.

(Reporting by Bhanu Pratap in Bengaluru; Editing by Amrutha Gayathri)

Related News

No French Open wild card for snubbed Sharapova

May 17, 2017

US-TENNIS-FRENCHOPEN-SHARAPOVA:No French Open wild card for snubbed Sharapova

Greek debt relief up to ministers after euro zone, IMF officials fail to break deadlock

May 16, 2017

US-EUROZONE-GREECE:Greek debt relief up to ministers after euro zone, IMF officials fail to break deadlock

France watches skies for Russian wargames, domestic drone threat

Feb 10, 2017

US-FRANCE-AIRFORCE-CONTROL:France watches skies for Russian wargames, domestic drone threat

Must Read

No French Open wild card for snubbed Sharapova

May 17, 2017

US-TENNIS-FRENCHOPEN-SHARAPOVA:No French Open wild card for snubbed Sharapova

Greek debt relief up to ministers after euro zone, IMF officials fail to break deadlock

May 16, 2017

US-EUROZONE-GREECE:Greek debt relief up to ministers after euro zone, IMF officials fail to break deadlock

France watches skies for Russian wargames, domestic drone threat

Feb 10, 2017

US-FRANCE-AIRFORCE-CONTROL:France watches skies for Russian wargames, domestic drone threat

Search
You May Need To Know

Obserworld delivers the most accurate and up-to-date world news for the global audience with a thorough research and in-depth interviews. Discover the world through Obserworld.

Contact us: sales@obserworld.com